All Stories

  1. CTEPH is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies

    Article • European Respiratory Journal, July 2024, European Respiratory Society (ERS)

    MD Pilar Rivera Ortega, Joanna Pepke-Zaba

  2. Pulmonary Embolism (PE) to Chronic Thromboembolic Pulmonary Disease (CTEPD): Findings from a Survey of UK Physicians

    Article • Advances in respiratory medicine, January 2024, MDPI AG

    Joanna Pepke-Zaba

  3. Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension

    Article • Nature Communications, January 2024, Springer Science + Business Media

    Joanna Pepke-Zaba

  4. Chronic Thromboembolic Pulmonary Hypertension: A Review of the Multifaceted Pathobiology

    Article • Biomedicines, December 2023, MDPI AG

    Joanna Pepke-Zaba

  5. Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension

    Article • Advances in Therapy, December 2023, Springer Science + Business Media

    Joanna Pepke-Zaba

  6. Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study

    Article • European Heart Journal, August 2023, Oxford University Press (OUP)

    Joanna Pepke-Zaba

  7. European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology

    Article • European Journal of Heart Failure, April 2023, Wiley

    Joanna Pepke-Zaba

  8. Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH—Results from a prospective discovery and validation biomarker study

    Article • The Journal of Heart and Lung Transplantation, March 2023, Elsevier

    Joanna Pepke-Zaba

  9. Corrigendum to: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respir...

    Article • European Heart Journal, February 2023, Oxford University Press (OUP)

    Joanna Pepke-Zaba

  10. Right ventricular–pulmonary artery coupling in chronic thromboembolic pulmonary hypertension

    Article • Heart, December 2022, BMJ

    Joanna Pepke-Zaba

  11. First Genotype–Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung Disease

    Article • American Journal of Respiratory and Critical Care Medicine, December 2022, American Thoracic Society

    Joanna Pepke-Zaba

  12. Prevalence and clinical significance of conduction disease in patients with idiopathic pulmonary arterial hypertension

    Article • The Journal of Heart and Lung Transplantation, July 2022, Elsevier

    Joanna Pepke-Zaba

  13. Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension

    Article • The Journal of Heart and Lung Transplantation, June 2022, Elsevier

    Joanna Pepke-Zaba

  14. Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival

    Article • CHEST Journal, June 2022, Elsevier

    Joanna Pepke-Zaba

  15. CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension

    Article • European Respiratory Journal, June 2020, European Respiratory Society (ERS)

    Joanna Pepke-Zaba